Webinar presenters Emilie Lalonde, PhD, FACMG, Molecular Geneticist and Cytogeneticist, Molecular Diagnostics Division, PaLM, London Health Sciences Centre and St. Joseph’s Health Care, Assistant Professor, Pathology and Laboratory Medicine, Western University, and Cheryl A. Mather, MD Medical Director, Molecular Pathology (North Sector), Alberta Precision Laboratories, Assistant Clinical Professor, Department of Laboratory Medicine & Pathology, University of Alberta, discuss how amplicon-based NGS panels meet biomarker testing guidelines in practice including routine diagnostics, expanded workup, and copy number variation (CNV) detection.
This on-demand webinar was originally broadcast on June 17, 2025.
What will this webinar empower you to do?
• Learn how amplicon-based NGS assays can be utilized to help manage patient treatment decisions.
• Engage with experienced customers specializing in routine diagnostics and breast cancer biomarker testing.
• Participate in an interactive Q&A with our distinguished speakers.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific.